Healthcare - Biotechnology - NASDAQ - US
$ 6.17
-5.8 %
$ 524 M
Market Cap
-4.67
P/E
Price Target
Average
197.14%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
21.61%
Net Income
Estimate
--3.32%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Terns Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for TERN of $18.3 , with forecasts ranging from a low of $10 to a high of $26 .
TERN Lowest Price Target
Wall Street Target
10 USD
62.07%
TERN Average Price Target
Wall Street Target
18.3 USD
197.14%
TERN Highest Price Target
Wall Street Target
26 USD
321.39%
REVENUE FORECAST
Revenue Forecast Chart TERN
EBIT FORECAST
EBIT Forecast Chart TERN
NET INCOME FORECAST
Net Income Chart TERN